<?xml version="1.0" encoding="UTF-8"?>
<p>Macroscale biomaterials strategies have recently boosted the field of immunotherapy.
 <sup>
  <xref ref-type="bibr" rid="ref153">153</xref>
 </sup> There are many advantages in controlled release and encapsulation of various cargos, ranging from small molecules to proteins and cells.
 <sup>
  <xref ref-type="bibr" rid="ref153">153</xref>
 </sup> These varied cargo elements can help to meet the need for diverse types of vaccine candidates. In terms of controlling PKs of vaccines, both sustained and pulsatile releases could be possibly achieved.
 <sup>
  <xref ref-type="bibr" rid="ref153">153</xref>
 </sup> In addition, materials engineering can enable devices that do not require surgically invasive administrations.
 <sup>
  <xref ref-type="bibr" rid="ref153">153</xref>
 </sup> Together, they could minimize the requirement of medical resources without mitigating the vaccine efficacy.
</p>
